BamSEC and AlphaSense Join Forces
Learn More

Synergy Pharmaceuticals, Inc.

Formerly NASDAQ: SGYP
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 34 pages Warrant Agency Agreement
12/34/56
EX-4.2
from S-3ASR 34 pages Synergy Pharmaceuticals Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 33 pages Synergy Pharmaceuticals Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.12
from 10-K 5 pages Synergy Pharmaceuticals Inc. and Wells Fargo Bank, National Association, as Trustee First Supplemental Indenture Dated as of February 28, 2017 to Indenture Dated as of November 3, 2014 7.50% Convertible Senior Notes Due 2019
12/34/56
EX-4.1
from S-3 2 pages Synergy Pharmaceuticals Incorporated Under the Laws of the State of Delaware Inc. Cusip 871639 30 8 See Reverse for Certain Definitions I I • 1 I J I R "-<' I " "Tl :;J=: Fully-Paid and Nonassessable Shares of the Common Stock, $0.0001 Par Value, of Jc> M,.... H B B "Tl :J: )> en ..... ;>; ..... :Ij 0 ("") Jz> E..n., M _:Ij Z President ''" ·'" "" I ?§ "" )S: "'" "'"" ' :Ss: R
12/34/56
EX-4.2
from S-3 30 pages Synergy Pharmaceuticals Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 29 pages Synergy Pharmaceuticals Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.2
from 8-K 15 pages Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company, a New York Corporation (“Dtc”), to the Company or Its Agent for Registration of Transfer, Exchange, or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or in Such Other Name as Is Requested by an Authorized Representative of Dtc (And Any Payment Hereunder Is Made to Cede & Co. or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge, or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Inasmuch as the Registered Owner Hereof, Cede & Co., Has an Interest Herein
12/34/56
EX-4.1
from 8-K 102 pages Synergy Pharmaceuticals Inc. and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of November 3, 2014 7.50% Convertible Senior Notes Due 2019
12/34/56
EX-4.2
from 8-K 15 pages Amended and Restated Synergy Pharmaceuticals, Inc. Unit Agency Agreement
12/34/56
EX-4.1
from 8-K 20 pages Amended and Restated Synergy Pharmaceuticals, Inc. Warrant Agency Agreement
12/34/56
EX-4.2
from 8-K 14 pages Synergy Pharmaceuticals, Inc. Unit Agency Agreement
12/34/56
EX-4.1
from 8-K 29 pages Synergy Pharmaceuticals, Inc. Warrant Agency Agreement
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Synergy Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant Synergy Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant Synergy Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Synergy Pharmaceuticals, Inc
12/34/56
EX-4.6
from 10-K 6 pages Synergy Pharmaceuticals, Inc. 17% Note Due: April 1, 2011
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant Synergy Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant Synergy Pharmaceuticals, Inc. Warrant Shares: Initial Exercise Date: , 2010
12/34/56